118 related articles for article (PubMed ID: 12195359)
1. Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response.
Mutimer HP; Akatsuka Y; Manley T; Chuang EL; Boeckh M; Harrington R; Jones T; Riddell SR
J Infect Dis; 2002 Sep; 186(5):701-5. PubMed ID: 12195359
[TBL] [Abstract][Full Text] [Related]
2. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
Wohl DA; Kendall MA; Owens S; Holland G; Nokta M; Spector SA; Schrier R; Fiscus S; Davis M; Jacobson MA; Currier JS; Squires K; Alston-Smith B; Andersen J; Freeman WR; Higgins M; Torriani FJ;
HIV Clin Trials; 2005; 6(3):136-46. PubMed ID: 16192248
[TBL] [Abstract][Full Text] [Related]
3. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis.
Schrier RD; Song MK; Smith IL; Karavellas MP; Bartsch DU; Torriani FJ; Garcia CR; Freeman WR
Retina; 2006 Feb; 26(2):165-9. PubMed ID: 16467672
[TBL] [Abstract][Full Text] [Related]
4. PCR with the aqueous humor, blood leukocytes and vitreous of patients affected by cytomegalovirus retinitis and immune recovery uveitis.
Siqueira RC; Cunha A; Oréfice F; Campos WR; Figueiredo LT
Ophthalmologica; 2004; 218(1):43-8. PubMed ID: 14688435
[TBL] [Abstract][Full Text] [Related]
5. [Two types of CMV ocular complications in patients with HIV infection].
Kozner P; Rozsypal H; Machala L; Filous A; Brozek B
Klin Mikrobiol Infekc Lek; 2009 Oct; 15(5):180-2. PubMed ID: 19916157
[TBL] [Abstract][Full Text] [Related]
6. Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses.
Hartigan-O'Connor DJ; Jacobson MA; Tan QX; Sinclair E;
Clin Infect Dis; 2011 Feb; 52(3):409-17. PubMed ID: 21189271
[TBL] [Abstract][Full Text] [Related]
7. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
Johnson SC; Benson CA; Johnson DW; Weinberg A
Clin Infect Dis; 2001 Mar; 32(5):815-9. PubMed ID: 11229851
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
Lin YC; Yang CH; Lin CP; Yang CM; Chen MS; Chen MY; Sheng WH; Hung CC; Chang SC
Ocul Immunol Inflamm; 2008; 16(3):83-7. PubMed ID: 18569793
[TBL] [Abstract][Full Text] [Related]
9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
10. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
[TBL] [Abstract][Full Text] [Related]
14. Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
Jacobson MA; Bredt BM
J Infect Dis; 2002 Dec; 186(11):1701-2; author reply 1702-3. PubMed ID: 12447752
[No Abstract] [Full Text] [Related]
15. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Hsieh SM; Pan SC; Hung CC; Tsai HC; Chen MY; Chang SC
J Infect Dis; 2001 Dec; 184(11):1386-91. PubMed ID: 11709780
[TBL] [Abstract][Full Text] [Related]
16. Immune recovery uveitis in a patient with previously undiagnosed cytomegalovirus retinitis.
Rangel CM; Prada AM; Varon C; Merayo-Lloves J
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26531739
[TBL] [Abstract][Full Text] [Related]
17. Proposed clinical case definition for cytomegalovirus-immune recovery retinitis.
Ruiz-Cruz M; Alvarado-de la Barrera C; Ablanedo-Terrazas Y; Reyes-Terán G
Clin Infect Dis; 2014 Jul; 59(2):298-303. PubMed ID: 24771331
[TBL] [Abstract][Full Text] [Related]
18. Immune recovery uveitis.
Kuppermann BD; Holland GN
Am J Ophthalmol; 2000 Jul; 130(1):103-6. PubMed ID: 11004267
[No Abstract] [Full Text] [Related]
19. Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis.
Wright ME; Suzman DL; Csaky KG; Masur H; Polis MA; Robinson MR
Clin Infect Dis; 2003 Apr; 36(8):1063-6. PubMed ID: 12684920
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
